BIBS Announces Recipients of New Frontiers Awards
The Brown Institute for Brain Science and the Norman Prince Neurosciences Institute have awarded New Frontiers Awards to three interdisciplinary research teams to help launch new, collaborative research projects related to diseases and disorders of the nervous system. These three projects focus on Obsessive Compulsive Disorder, stroke and the long-term effects of early life stress on brain development and mental health
This is the fifth round of awards through this program since 2013. All projects involve collaborations between campus-based and hospital-based faculty members. The goal is to build research teams focused on brain health that include basic and clinical researchers. The awards provide $40,000 for one year and teams are able to apply for a second year of support if they show exceptional progress. The expectation is that successful projects will develop into enduring, externally funded research programs.
Funding for New Frontiers Awards comes from BIBS and NPNI, with contributions from the home departments of the co-principal investigators.
The three awards approved in this round include:
1. Goal Directed Behavior and Uncertainty in Obsessive Compulsive Disorder
Christina Boisseau, PhD
Assistant Professor (Research)
Department of Psychiatry and Human Behavior
Michael Frank, PhD
Department of Cognitive, Linguistic, and Psychological Sciences
This project investigates uncertainty and the interaction between goal-directed behavior and habitual behavior in patients with obsessive compulsive disorder (OCD). It brings together a hospital based team led by Dr. Boisseau that has broad experience in the psychopathology and treatment of obsessive compulsive disorder, and a group of campus investigators led by Dr. Frank that has a primary interest in computational psychiatry, reinforcement learning and the neural architecture of habitual and goal-directed behaviors. Together they will begin to tease apart ways that habitual and goal-directed behaviors differ in OCD patients compared to normal individuals and set the stage for future studies incorporating EEG and functional imaging studies to develop neural metrics that underlie OCD and can be used to track the efficacy of different therapies. This is the beginning of one of the few efforts worldwide to bridge the gap between psychiatry and computational neuroscience.
2. Tissue Engineered Platform for Stroke Investigation – 3D Neuronal Microtissues
Karen Furie, MD
Samuel I. Kennison, MD, and Bertha S. Kennison Professor of Clinical Neuroscience and Chair
Department of Neurology
Diane Hoffman-Kim, PhD
Department of Molecular Pharmacology Physiology and Biotechnology
This program will develop novel 3D neuronal culture systems that can be adapted as experimental models of stroke. It will combine the clinical expertise of Dr. Furie, a highly accomplished stroke neurologist, with the experimental expertise of Dr. Hoffman-Kim, who has developed techniques for making 3D neuronal microtissues from mouse cortical neurons, or from neurons derived from human induced pluripotent stem cells. These microtissues display many of the features of the in vivo nervous system and will be subjected to various states of oxygen and glucose deprivation in culture to identify the conditions under which they mimic stroke in patients. They will then be used to evaluate the protective abilities of drugs that are candidates for mitigating the long term effects of stroke. These will be the initial steps in creating an effective, high throughput model system for testing stroke therapeutics.